Jennifer L. Eitson

2.3k total citations
23 papers, 750 citations indexed

About

Jennifer L. Eitson is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Jennifer L. Eitson has authored 23 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Jennifer L. Eitson's work include Mosquito-borne diseases and control (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Viral Infections and Vectors (4 papers). Jennifer L. Eitson is often cited by papers focused on Mosquito-borne diseases and control (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Viral Infections and Vectors (4 papers). Jennifer L. Eitson collaborates with scholars based in United States, Sweden and Denmark. Jennifer L. Eitson's co-authors include John W. Schoggins, R. Blake Richardson, Nicolai S. C. van Oers, Serkan Belkaya, Katrina B. Mar, Ian N. Boys, Natasha W. Hanners, M. Teresa de la Morena, Matthew B. McDougal and Nicholas Rinkenberger and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jennifer L. Eitson

21 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jennifer L. Eitson United States	15	290	237	222	150	121	23	750
Kelly A. Metcalf Pate United States	16	170 0.6×	226 1.0×	179 0.8×	126 0.8×	61 0.5×	39	810
Amanda L. Aloia Australia	18	349 1.2×	120 0.5×	144 0.6×	127 0.8×	123 1.0×	28	701
Luke W. Meredith United Kingdom	17	376 1.3×	292 1.2×	130 0.6×	578 3.9×	129 1.1×	38	1.3k
María Rosa López‐Huertas Spain	21	331 1.1×	505 2.1×	377 1.7×	244 1.6×	40 0.3×	46	1.2k
Nicole A. P. Lieberman United States	16	264 0.9×	316 1.3×	246 1.1×	169 1.1×	42 0.3×	33	903
Michelli F. Oliveira United States	19	384 1.3×	515 2.2×	216 1.0×	228 1.5×	56 0.5×	30	1.2k
Marina Vaysburd United Kingdom	21	462 1.6×	257 1.1×	499 2.2×	178 1.2×	55 0.5×	29	1.2k
Benjamin A. Krishna United Kingdom	22	369 1.3×	188 0.8×	306 1.4×	797 5.3×	150 1.2×	37	1.3k
Henrik Svensson Sweden	13	216 0.7×	137 0.6×	435 2.0×	94 0.6×	218 1.8×	18	984
Derek D.C. Ireland United States	17	159 0.5×	300 1.3×	356 1.6×	239 1.6×	244 2.0×	37	877

Countries citing papers authored by Jennifer L. Eitson

Since Specialization

Citations

This map shows the geographic impact of Jennifer L. Eitson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer L. Eitson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer L. Eitson more than expected).

Fields of papers citing papers by Jennifer L. Eitson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer L. Eitson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer L. Eitson. The network helps show where Jennifer L. Eitson may publish in the future.

Co-authorship network of co-authors of Jennifer L. Eitson

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer L. Eitson. A scholar is included among the top collaborators of Jennifer L. Eitson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer L. Eitson. Jennifer L. Eitson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hernandez, Genaro, Adam Osinski, Jennifer L. Eitson, et al.. (2025). Covalent inhibition of the SARS-CoV-2 NiRAN domain via an active-site cysteine. Journal of Biological Chemistry. 301(4). 108378–108378.

Kober, Daniel L., Jennifer L. Eitson, Ian N. Boys, et al.. (2024). Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo. mBio. 15(6). e0076824–e0076824.

Mar, Katrina B., Alexandra I. Wells, Jennifer L. Eitson, et al.. (2023). LY6E is a pan-coronavirus restriction factor in the respiratory tract. Nature Microbiology. 8(8). 1587–1599. 15 indexed citations

Ahmed, Mahmoud, Ayman Farag, Ian N. Boys, et al.. (2023). FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms. Biomedicine & Pharmacotherapy. 162. 114614–114614. 7 indexed citations

Rehfeld, Frederick, Jennifer L. Eitson, Maikke B. Ohlson, et al.. (2023). CRISPR screening reveals a dependency on ribosome recycling for efficient SARS-CoV-2 programmed ribosomal frameshifting and viral replication. Cell Reports. 42(2). 112076–112076. 14 indexed citations

Ohlson, Maikke B., Jennifer L. Eitson, Alexandra I. Wells, et al.. (2023). Genome-Scale CRISPR Screening Reveals Host Factors Required for Ribosome Formation and Viral Replication. mBio. 14(2). e0012723–e0012723. 9 indexed citations

Osinski, Adam, Genaro Hernandez, Jennifer L. Eitson, et al.. (2022). The mechanism of RNA capping by SARS-CoV-2. Nature. 609(7928). 793–800. 76 indexed citations

Jain, Mamta K., James A. de Lemos, Darren K. McGuire, et al.. (2022). Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial. Frontiers in Pharmacology. 13. 1020123–1020123. 4 indexed citations

Hanners, Natasha W., Katrina B. Mar, Ian N. Boys, et al.. (2021). Shiftless inhibits flavivirus replication in vitro and is neuroprotective in a mouse model of Zika virus pathogenesis. Proceedings of the National Academy of Sciences. 118(49). 20 indexed citations

10.

Li, Elizabeth, Jun Guo, Yerim Kim, et al.. (2021). Anterograde transneuronal tracing and genetic control with engineered yellow fever vaccine YFV-17D. Nature Methods. 18(12). 1542–1551. 20 indexed citations

11.

Boys, Ian N., et al.. (2020). RTP4 Is a Potent IFN-Inducible Anti-flavivirus Effector Engaged in a Host-Virus Arms Race in Bats and Other Mammals. Cell Host & Microbe. 28(5). 712–723.e9. 35 indexed citations

12.

Mar, Katrina B., Nicholas Rinkenberger, Ian N. Boys, et al.. (2018). LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step. Nature Communications. 9(1). 3603–3603. 93 indexed citations

13.

Rosenberg, Brad R., Catherine A. Freije, Naoko Imanaka, et al.. (2017). Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients. The Journal of Infectious Diseases. 217(4). 650–655. 15 indexed citations

14.

Perelman, Sofya S., Michael E. Abrams, Jennifer L. Eitson, et al.. (2016). Cell-Based Screen Identifies Human Interferon-Stimulated Regulators of Listeria monocytogenes Infection. PLoS Pathogens. 12(12). e1006102–e1006102. 23 indexed citations

15.

Hanners, Natasha W., Jennifer L. Eitson, Noriyoshi Usui, et al.. (2016). Western Zika Virus in Human Fetal Neural Progenitors Persists Long Term with Partial Cytopathic and Limited Immunogenic Effects. Cell Reports. 15(11). 2315–2322. 94 indexed citations

16.

Feenstra, Bjarke, Björn Pasternak, Frank Geller, et al.. (2014). Common variants associated with general and MMR vaccine–related febrile seizures. Nature Genetics. 46(12). 1274–1282. 106 indexed citations

17.

Belkaya, Serkan, et al.. (2013). Transgenic Expression of MicroRNA-185 Causes a Developmental Arrest of T Cells by Targeting Multiple Genes Including Mzb1. Journal of Biological Chemistry. 288(42). 30752–30762. 35 indexed citations

18.

Morena, M. Teresa de la, Jennifer L. Eitson, Igor Dozmorov, et al.. (2013). Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome. Clinical Immunology. 147(1). 11–22. 51 indexed citations

19.

Eitson, Jennifer L., Ashley R. Hoover, Shashikant Srivastava, et al.. (2012). Mycobacterial Shuttle Vectors Designed for High-Level Protein Expression in Infected Macrophages. Applied and Environmental Microbiology. 78(19). 6829–6837. 11 indexed citations

20.

Becker, Amy M., Jon S. Blevins, Farol L. Tomson, et al.. (2010). Invariant NKT Cell Development Requires a Full Complement of Functional CD3 ζ Immunoreceptor Tyrosine-Based Activation Motifs. The Journal of Immunology. 184(12). 6822–6832. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact